NAD+ metabolism and therapeutic strategies in cardiovascular diseases
Open Access
- 11 June 2024
- journal article
- research article
- Published by Elsevier in Atherosclerosis Plus
- Vol. 57, 1-12
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Commission of Health (LKM2022060)
- Nanning Science and Technology Bureau (JC12022017)
- National Natural Science Foundation of China (82200462, 2018YFA0801004)
- Nantong University
This publication has 158 references indexed in Scilit:
- NAD+ administration decreases microvascular damage following cardiac ischemia/reperfusion by restoring autophagic fluxBasic Research in Cardiology, 2020
- Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3‐dependent mechanism in male miceJournal of Neuroscience Research, 2019
- Effect of resveratrol and pterostilbene on aging and longevityBioFactors, 2017
- Role of resveratrol in regulation of cellular defense systems against oxidative stressBioFactors, 2017
- N‐methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E‐deficient miceMolecular Nutrition & Food Research, 2016
- A Perspective on Chemoprevention by Resveratrol in Head and Neck Squamous Cell Carcinoma2014
- Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic ImplicationsMedicinal Research Reviews, 2013
- Effect of nadcin on energy supply system and apoptosis in ischemia-reperfusion injury to the myocardiumBulletin of Experimental Biology and Medicine, 2008
- Effect of NAD on recovery of adenine nucleotide pool, phosphorylation potential, and stimulation of apoptosis during late period of reperfusion damage to myocardiumBulletin of Experimental Biology and Medicine, 2005
- Myocardial Ischemic Preconditioning in Rodents Is Dependent on Poly (ADP-Ribose) SynthetaseMolecular Medicine, 2001